HNB
FCSC

Huntington National Bank’s Fibrocell Science Inc. FCSC Stock Holding History

Huntington National Bank’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1
Closed – – 1660
2013
Q4 		$0 Hold
1
– – ﹤0.01% 1762
2013
Q3 		$0 Hold
1
– – ﹤0.01% 1783
2013
Q2 		$0 Buy
+1
New +$83 ﹤0.01% 1747

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BGA
Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Huntington National Bank's FCSC Position: Q1 2014 in Review

Huntington National Bank sold out of Fibrocell Science Inc. (FCSC) in Q1 2014, closing a stake of 1 share.

Huntington National Bank first reported a position in FCSC in Q2 2013 and held it in 3 quarters. The position peaked at $0 in Q4 2013. 46 funds tracked by Wall St. Rank hold FCSC as of Q1 2014.

  • Huntington National Bank reported no remaining Fibrocell Science Inc. position as of Q1 2014 after selling out during the quarter.
  • Huntington National Bank sold 1 Fibrocell Science Inc. share in Q1 2014.
  • Huntington National Bank first reported a position in Fibrocell Science Inc. in Q2 2013 and held it in 3 quarters.
  • Huntington National Bank's Fibrocell Science Inc. position peaked at $0 in Q4 2013.
  • 46 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q1 2014.

Based on Huntington National Bank's 13F filing for Q1 2014, filed 27 May 2014.